Largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis. The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.
The breast imaging market is projected to grow from an estimated USD 3.1 billion in 2018 to USD 4.6 billion by 2023, at a CAGR of 8.0% during the forecast period.
Major Key Players of the Breast Imaging Market are:
Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), and Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France).
Get a Sample PDF Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=897
Major Types of Breast Imaging Market covered are:
Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography
Recent Developments:
In 2018, Hologic, Inc. received FDA approval for its innovations on the 3Dimensions Mammography System.
In 2017, CMR Naviscan Corporation (US) acquired certain assets and intellectual property of Gamma Medica Molecular Breast Imaging (MBI) Technology with the aim to expand its Breast PET Imaging (BPI) Solutions.
In 2017, Canon, Inc. (Japan) established the Yokohama Development Center in Tsurumi Ward, Yokohama, with the aim to expand its operations and pioneer new business opportunities.
Go For Interesting Discount Here:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=897
The Asia Pacific is one of the major revenue-generating regions in the breast imaging market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries focusing on the improvement of breast health. Furthermore, the increasing geriatric population and the growing incidence of breast cancer are also driving the growth of this regional market.
